| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 277 | 2,185,183 | ABVX, PTGX, ROIV, SPY | 13F-HR | 8/14/2026 | 000194027226000015 |
| Q1 2026 | 310 | 1,698,675 | ABVX, PTGX, ROIV, IMVT | 13F-HR | 5/18/2026 | 000194027226000005 |
| Q4 2025 | 270 | 1,361,602 | ABVX, PTGX, ROIV, IMVT | RESTATEMENT | 2/18/2026 | 000194027226000003 |
| Q3 2025 | 217 | 1,064,573 | ABVX, KROS, PTGX, ROIV | 13F-HR | 11/14/2025 | 000194027225000008 |
| Q2 2025 | 210 | 652,087 | KROS, PTGX, BOXX, ZLAB | 13F-HR | 8/14/2025 | 000194027225000005 |
| Q1 2025 | 202 | 538,666 | PTGX, BOXX, ROIV, ZLAB | 13F-HR | 5/15/2025 | 000194027225000003 |
| Q4 2024 | 214 | 500,371 | ROIV, PTGX, BOXX, ZLAB | 13F-HR | 2/13/2025 | 000194027225000001 |
| Q3 2024 | 278 | 614,885 | CYTK, PTGX, BBIO, BOXX | 13F-HR | 11/14/2024 | 000194026724000005 |
| Q2 2024 | 266 | 529,701 | PTGX, CYTK, ROIV, BOXX | 13F-HR | 8/13/2024 | 000194026724000001 |
| Q1 2024 | 261 | 440,787 | ALNY puts, BOXX, ROIV, SPY puts | 13F-HR | 5/15/2024 | 000194027224000003 |
| Q4 2023 | 170 | 279,822 | ALNY puts, RPRX, KROS, ROIV | 13F-HR | 2/14/2024 | 000194027224000002 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||||
|
Keros Therapeutics, Inc.
13D/A
KROS · 492327101
|
0% |
10/15/2025
Event 10/15/2025
|
||||
| ADAR1 Capital Management, LLC | 0% | |||||
| ADAR1 Capital Management GP, LLC | 0% | |||||
| Daniel Schneeberger | 0% | |||||
33 other securities where the latest filing is a 13G, the newest filed 10/7/2026. View all